Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
Suppressed Th17 levels correlated with upregulated expression of negative regulatory genes, PIAS3, SHP2, and SOCS3 in CD4 T cells during acute SIV infection.
Data indicate that PIAS3 (protein inhibitor of activated STAT3) interaction modulates EKLF (erythroid Kruppel-like factor (show KLF1 ELISA Kits)) activity in a promoter-dependent and SUMO-independent manner.
PIAS3 suppresses acute graft-versus-host disease by modulating effector T and B cell subsets through inhibition of STAT3 (show STAT3 ELISA Kits) activation.
These data indicate that tachypacing decreased ATBF1 (show ZFHX3 ELISA Kits), leading to enhanced STAT3 (show STAT3 ELISA Kits) DNA-binding activity due to the reduced formation of a binary complex of ATBF1 (show ZFHX3 ELISA Kits) and PIAS3.
MRL/lpr (show FAS ELISA Kits) mice have significantly increased expressions of STAT3 (show STAT3 ELISA Kits) mRNA and protein and decreased expression of mRNA PIAS3 in the kidneys compared with BALB/C mice.
L97A, R99N and R99Q mutations of the PINIT domain (PIAS3(85-272) ) were found to abrogate binding to STAT3 (show STAT3 ELISA Kits), suggesting that these residues were part of a potential binding surface.
Our results indicate that Pias3-dependent SUMOylation of photoreceptor-specific transcription factors is a common mechanism that controls both rod and cone photoreceptor subtype specification, regulating distinct molecular targets in the two cell types
there is an interaction between Zimp7 (show ZMIZ2 ELISA Kits) and PIAS (show PIAS1 ELISA Kits) proteins with higher preference for PIAS3, in androgen receptor (show AR ELISA Kits)-mediated transcription
results indicate a potential role of PIAS3 as transcriptional modulator of TIF2 (show NCOA2 ELISA Kits)-mediated signalling
role in inducing SUMO-1 (show SUMO1 ELISA Kits) modification and transcriptional repression of IRF-1 (show IRF1 ELISA Kits)
identified a novel conserved domain of 180 residues in PIAS (show PIAS1 ELISA Kits) proteins and showed that its 'PINIT' motif as well as other conserved motifs (in the SAP (show APCS ELISA Kits) box and in the RING domain) are independently involved in nuclear retention of PIAS3L
PAI-1 (show SERPINE1 ELISA Kits) interacted with PIAS3 to regulate Stat3 (show STAT3 ELISA Kits)-dependent gene expression and miR (show MLXIP ELISA Kits)-34a was transcriptionally suppressed by Stat3 (show STAT3 ELISA Kits) to form a positive regulatory loop through Stat3 (show STAT3 ELISA Kits) signaling in non-small cell lung cancer cells.
Levels of PIAS3 are significantly lower, in contrast with phosphorylation of STAT3 (show STAT3 ELISA Kits), in women with endometriosis compared to women without endometriosis.
TRIM8 (show TRIM8 ELISA Kits) activates STAT3 (show STAT3 ELISA Kits) by suppressing the expression of PIAS3, an inhibitor of STAT3 (show STAT3 ELISA Kits), most likely through E3-mediated ubiquitination and proteasomal degradation.
Low PIAS3 expression is associated with breast cancer organoid invasiveness.
SHP2 (show PTPN11 ELISA Kits), SOCS3 (show SOCS3 ELISA Kits) and PIAS3 levels are reduced in medulloblastomas in vivo and in vitro, of which PIAS3 downregulation is more reversely correlated with STAT3 (show STAT3 ELISA Kits) activation. In resveratrol-suppressed medulloblastoma cells with STAT3 (show STAT3 ELISA Kits) downregulation and decreased incidence of STAT3 (show STAT3 ELISA Kits) nuclear translocation, PIAS3 is upregulated, the SHP2 (show PTPN11 ELISA Kits) level remains unchanged and SOCS3 (show SOCS3 ELISA Kits) is downregulated.
The results revealed that although the expression levels of SOCS1 (show SOCS1 ELISA Kits), SOCS3 (show SOCS3 ELISA Kits) and, in particular, pSHP2, tend to decrease in the four types of astrocytomas, PIAS3 downregulation is more negatively correlated with STAT3 (show STAT3 ELISA Kits) activation in the stepwise progress of astrocytomas and would indicate an unfavorable outcome.
3-Formylchromone inhibits proliferation and induces apoptosis of multiple myeloma cells by abrogating STAT3 (show STAT3 ELISA Kits) signaling through the induction of PIAS3.
PIAS3 may serve as a biomarker for predicting hormone therapy stratification, although it is limited to those breast cancer patients receiving hormone therapy.
Taken together, these results suggest that PIAS3 functions as a positive regulator of HIF-1alpha (show HIF1A ELISA Kits)-mediated transcription by increasing its protein stability.
PIAS3 suppression may be protective against joint destruction in rheumatoid arthritis by regulating synoviocyte migration, invasion, and activation.
This gene encodes a member of the PIAS
protein inhibitor of activated STAT, 3
, E3 SUMO-protein ligase PIAS3-like
, e3 SUMO-protein ligase PIAS3-like
, E3 SUMO-protein ligase PIAS3
, protein inhibitor of activated STAT protein 3
, zinc finger, MIZ-type containing 5
, potassium channel regulatory protein KChAP
, potassium channel-associated protein